No video
#HEMEPATH
Рет қаралды 3,026
Күн бұрынDr. Sanam Loghavi, MD, Associate Professor, Department of Hematopathology, MD Anderson Cancer Center, USA, discusses "Navigating Change and Integrating WHO 5th/ ICC Classification Systems in the diagnosis of AML and MDS"
Follow #pathCast on:
KZfaq: / @pathcast
X : / pathologycast
Instagram: / pathcast2016
Website: pathologycast....
@Torecan Ай бұрын
In minute 26, refering to AML defining genetic abnormalities classification I don't think is that clear that WHO establishes distinction regarding the number of blast requirement (increased vs no minimum threshold). I've checked the WHO 5th classification online resource and it says for NPM1 "Essential (diagnostic criteria): a myeloid neoplasm with increased peripheral blood and/or bone marrow blasts (may be < 20%)" which is just the same comment than for RUNX1... However I'm sure dr Loghavi had good reasons to make that comment
@simazolfaghari5963 4 ай бұрын
Thank you!
@justsmilejustsmile3155 4 ай бұрын
Thank you❤
@larkinwalker6659 4 ай бұрын
Thank you!
pathCast
Рет қаралды 3,5 М.
Touch Medical Media Services
Рет қаралды 2,6 М.
pathCast
Рет қаралды 3,3 М.
Medicosis Perfectionalis
Рет қаралды 418 М.
AAMDSIF
Рет қаралды 4,6 М.
pathCast
Рет қаралды 14 М.
The Diary Of A CEO
Рет қаралды 6 МЛН